Article PDF
References
Bouck NP (1990) Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells 2:179–185
Denekamp J (1990) Vascular attack as a therapeutic strategy for cancer. Cancer Met Rev 9:267–282
Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442–447
Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348:555–557
Klagsbrun M (1990) The fibroblast growth factor family: structural and biological properties. Prog Growth Factor Res 1:207–235
Kusaka M, Sudo K, Fujita T, Marui S, Itoh F, Ingber D, Folkman J (1991) Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun 174:1070–1076
Schweigerer L (1990) Anti-Angiogenese als neues Konzept zur Therapie ungehemmter Neovaskularisation. Dtsch Aerztebl 50A:4050
Schweigerer L (1990) Basic fibroblast growth factor: properties and clinical implications. In: Habenicht AJR (ed) Growth factors, differentiation factors, and cytokines. Springer, Berlin Heidelberg New York, pp 42–55
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schweigerer, L. Anti-angiogenesis as a new concept for the therapy of neovascular diseases. Klin Wochenschr 69, 417–418 (1991). https://doi.org/10.1007/BF01666825
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01666825